Last week Intuitive Surgical (ISRG) surprised everybody, including, apparently, management. Intuitive Surgical’s first-quarter revenue grew 14% year-over-year to $1.7 billion. (Wall Street was expecting $1.6 billion.) Surgical procedures performed using the company’s da Vinci system, rose 26% year-over-year, well above expectations for 15% growth. And the company raised guidance for global procedure growth to 18% to 21% from the prior guidance of 12% to 16%.
Today, April 28, I’m selling Intuitive Surgical out of my Jubak Picks Portfolio with a 9.39% gain since February 15. I think the shares are fully valued here (or perhaps over-valued if there is such a thing anymore in this market) and I’d like to have some more cash just in case”something” creates a little volatility in the financial markets.
Yesterday, April 20, after the market close Intuitive Surgical (ISRG) reported first quarter GAAP earnings of $3.51 a share, $1.47 a share above Wall Street estimates. Non-GAAP earnings of $3.52 were 89 cents a share above analyst expectations. Revenue for the quarter climbed to $1.3 billion, up 18% from the first quarter of 2020. In 2020 sales of the company’s robotic surgery systems, dropped to $4.4 billion from $4.5 billion in 2019 as hospitals halted elective surgeries during the pandemic. I added the shares to my Jubak Picks Portfolio on February 15, 2021 on expectations with in a post-vaccine global economy sales of its da Vinci Surgical Systems would rebound strongly. In the first quarter the company shipped 298 de Vinci systems versus 237 in the first quarter of 2020. As of 3:45 p.m. New York time today, Intuitive Surgical share were up 9.50% to $888.10. That exceeds my target of $860 a share and I’ll be looking to sell the shares sometime in the next couple of weeks after I’ve received the full benefit from a positive earnings season for BIG TECH stocks.
Special Report: Profit and Protect–What you need to know about stock market stages for 2021–Stage 2 of 3: My rules for selling in the “When you win, you lose market” (and sells of ILMN, CTVA, WST, and VMW)
On to Stage #2 in my Special Report: “Profit and Protect–What you need to know about stock market stages for 2021. And to my rules for the sells and hedges in Stage #2 for 2021: When you win, you lose. (I just posted sells for ILMN, CTVA, WST and VMW)
Intuitive Surgical Pick #10 for my new Millennial Portfolio (for investors who have more time than money); also adding it to Jubak Picks
In my first 10 (actually to be 11 since I’ve got another pick up my sleeve) picks for my new Millennial Portfolio (for investors who have more time than money) I’ve been on the hunt for shares of companies with long, long revenue and earnings growth runways ahead of them, with short-term catalysts that might produce enough of a gain in the near term to keep investors on board for the long run, and some bad news in the present that been negative enough to take a bite of the stock price. Today, February 15, I’m adding Intuitive Surgical to my Millennial Portfolio and to my Jubak Picks Portfolio